NeoGenomics Unveils 2024: A Year in Review – Unraveling the Fourth Quarter’s Surprising Findings!
NeoGenomics: Unraveling the Mysteries of the Fourth Quarter and Full Year Results FORT MYERS, Fla. – In a recent press release, NeoGenomics, a leading provider of cancer-focused genetic testing services, shared their financial results for the fourth quarter and full year ended December 31, 2024. Let’s delve into the details and explore what these numbers…